LEUMAS LIMITED

Leumas Limited is a pioneer in on‑demand, robot‑driven manufacturing for the pharmaceutical and wellness sectors. By combining modular, reconfigurable factories with AI‑led software, the company delivers FDA‑compliant production that can move seamlessly from early‑stage development to full‑scale commercial output. Their “robot factories” are purpose‑built to provide resilient, distributed supply chains, enabling rapid change‑overs, minimal downtime and a radically better cost‑to‑value equation for partners.

The service portfolio spans the entire product lifecycle for oral solids, liquids, semi‑solids, nutraceuticals, health foods, personal‑care and cosmeceutical dosage forms. Clients benefit from capital‑efficient scale‑up, faster development timelines and leaner launches, all without the need to build up large inventories. Leumas’ dedicated, private factories can be re‑configured in weeks to support reshoring, new‑market expansion or parallel development programmes, giving manufacturers the agility required for precision‑medicine at scale.

With a recent US$2.2 million seed investment, Leumas is positioned to transform how pharma and wellness brands bring innovative products to market, offering a digitalised, end‑to‑end manufacturing advantage that improves working capital